Cutibacterium acnes

Cutibacterium acnes (formerly Propionibacterium acnes; reclassified in 2016 ¹) is the dominant commensal bacterium of sebaceous follicles on human skin, constituting the majority of the skin microbiome on sebum-rich regions (face, scalp, upper back, chest). An aerotolerant anaerobic gram-positive rod, it colonizes pilosebaceous units and metabolizes sebum-derived triglycerides into short-chain fatty acids (primarily propionic and acetic acids) that maintain the acidic skin surface pH (~4.5–5.5) and suppress pathogen colonization. While widely known as the pathobiont associated with acne vulgaris, C. acnes is better understood as a commensal whose ecological disruption — rather than simple overgrowth — drives inflammatory disease. In the context of skin aging, it links to dysbiosis through age-dependent sebum decline that reduces C. acnes dominance, shifts phylotype composition, and may compromise skin barrier function and pathogen exclusion.

Identity

Field	Value
Species	Cutibacterium acnes (Tubaki & Nishida 1965) Scholz & Kilian 2016
Former name	Propionibacterium acnes (Gilchrist 1900) Douglas & Gunter 1946
NCBI Taxonomy ID	1747
Phylum	Actinomycetota (Actinobacteria)
Class	Actinomycetes
Order	Propionibacteriales
Family	Propionibacteriaceae
Gram stain	Positive
Morphology	Rod-shaped, non-motile, non-spore-forming, pleomorphic
Oxygen tolerance	Aerotolerant anaerobe (grows anaerobically; tolerates O₂ but does not require it)
Reference strain	KPA171202 (genome reference; ATCC 6919 is older deposited type strain)
Genome size	~2.5 Mb (typical clinical isolates ~2.4–2.6 Mb) ²
G+C content	~60% (typical for Actinobacteria)
Named for	Cutis (skin) + bacterium; propionate production from propionibacteria

The reclassification from Propionibacterium to Cutibacterium in 2016 resolved a long-standing phylogenetic discrepancy between 16S rRNA-based and core-genome-based phylogeny ¹. Three new genera were proposed to replace polyphyletic Propionibacterium: Acidipropionibacterium (dairy species), Cutibacterium (cutaneous species including C. acnes, C. avidum, C. granulosum), and Pseudopropionibacterium. The species epithet acnes is retained.

Phylotypes

C. acnes is a highly heterogeneous species. Multi-locus sequence typing (MLST) and whole-genome sequencing identify six phylotypes (IA1, IA2, IB, IC, II, III) with distinct ecological roles, virulence potential, and disease associations ³ ²:

Phylotype	Alternative designation	Disease association	Ecological notes
IA1	Type 1A1	Acne-associated (dominant in acne lesions)	Biofilm-forming; more virulent in skin-cell assays; encodes CAMP factor, sialidase, hyaluronidase
IA2	Type 1A2	Moderate acne association	Less characterized than IA1
IB	Type 1B	Commensal-skewed	Common in healthy follicles; shoulder implant infections
IC	Type 1C	Rare; emerging characterization	needs-replication
II	Type 2	Commensal-skewed	More common in older adults; less acne-promoting
III	Type 3	Commensal-skewed	Rare; associated with healthy skin

Acne vulgaris involves loss of phylotype diversity, not hyperproliferation of C. acnes overall — the total C. acnes load is comparable between acne-prone and clear skin, but the ratio shifts toward IA1 dominance ⁴. needs-replication on specific phylotype-to-disease mapping; most data are observational 16S rRNA or MLST studies.

Multi-omics analysis by Yu et al. 2024 confirmed that body site and skin disease state (acne vs atopic dermatitis vs healthy) shape C. acnes genomic composition through horizontal gene transfer and positive selection, with sebum-rich environments correlating with increased pro-inflammatory gene expression ². no-fulltext-access — specific isolate count (cited as 1,234 in seeder notes) unverified against full-text; paper is not_oa.

Niche and ecology

Pilosebaceous unit colonization

C. acnes occupies a highly specific niche: the pilosebaceous unit (hair follicle + sebaceous gland). The follicular canal is relatively anaerobic — oxygen tension decreases from the follicular opening toward the base, providing conditions favorable for C. acnes growth. Its primary carbon and energy source is sebum, a lipid mixture secreted by sebaceous glands containing triglycerides (~57%), wax esters (~26%), squalene (~12%), and free fatty acids (~15%) ⁴.

Key metabolic features:

Lipases (principally lipase A; encoded by lip1/lip2): hydrolyze sebum triglycerides into glycerol and free fatty acids (FFAs), particularly oleic, linoleic, and palmitic acids. These FFAs serve as carbon source and are antimicrobial to other organisms at low follicular pH.
Propionic acid production: fermentation of amino acids and glycerol generates propionate and acetate via the Wood-Werkman cycle; these organic acids contribute to the acidic skin surface pH (~4.5–5.5) that inhibits pathogen growth.
Porphyrin production: C. acnes produces coproporphyrin III and protoporphyrin IX, which are photoreactive and visible under Wood’s lamp (orange-red fluorescence). Their accumulation in acne lesions contributes to follicular inflammation.

The organism depends on sebum availability. Sebum production is primarily androgen-regulated: rises sharply at adrenarche (~8 yr), peaks in early adulthood (~20s–30s), and declines substantially post-menopause and in late middle age in both sexes (~40–60% reduction in sebum output between age 20 and 70) ⁴. needs-replication — specific magnitude and timeline of sebum decline require confirmation against a targeted primary source.

Competitive exclusion and skin homeostasis

In healthy skin, C. acnes provides several protective functions ⁴ ⁵:

Pathogen exclusion: acidic pH (~4.5–5.5) and FFA production suppress Staphylococcus aureus and other transient pathogens; C. acnes fermentation products are bacteriostatic against gram-negative organisms.
Interaction with Staphylococcus epidermidis: S. epidermidis produces lactic acid and bacteriocins that modulate C. acnes biofilm formation; the two species co-regulate follicular homeostasis. Disruption of either (e.g., by antibiotic treatment) dysregulates both ⁴.
Antioxidant capacity: cell-free supernatant of commensal C. acnes strains demonstrates significant DPPH and ABTS radical-scavenging activity and activates the Nrf-2 oxidative stress pathway in keratinocytes in vitro ⁵. This finding positions specific commensal C. acnes strains as potential “skin probiotics.” needs-human-replication — all evidence is in vitro.
Immune education: C. acnes stimulates TLR2 on keratinocytes and sebocytes at baseline, priming innate immune responses without overtly inflammatory signaling under commensal conditions. TNIP1 (TNF-α-induced protein 3-interacting protein 1) acts as a negative regulator of TLR2/TLR4 downstream of C. acnes stimulation, keeping immune tone calibrated ⁶.

Aging context

Sebum decline drives C. acnes reduction with age

The most robust age-related change in C. acnes ecology is quantitative decline tracking sebum production. Cross-sectional skin microbiome studies consistently find that C. acnes relative abundance is highest on the face and upper trunk in young adults (20s–30s), and declines with age as sebum output falls ⁷ ⁸:

Jung et al. 2024 (n=60 Korean adults — 30 aged 20–29 yr, 30 aged 60–75 yr; whole-metagenome sequencing, nasolabial fold) found older adults showed decreased C. acnes dominance and increased microbial diversity compared to younger adults, correlating with reduced skin elasticity and increased wrinkle scores ⁷. needs-replication — single-cohort, cross-sectional, observational design; causal direction unestablished.
Swaney et al. 2025 (n=59 UK adults — 30 young age [YA] 26.7 ± 4.45 yr, 29 old age [OA] 72.3 ± 4.04 yr; 16S rRNA V1-V3, face and forearm) identified C. acnes as one of the “key differentiating biomarkers of the skin microbiome across the lifespan” alongside S. hominis and diversity metrics, with site-specific dynamics (face: C. acnes significant decrease in OA, p=0.033; arm: significant decrease, p=0.0078) ⁸. needs-replication — observational; gender-driven effect noted (facial C. acnes decline significant only in female participants).

Post-menopausal women show particularly pronounced sebum reduction — estrogen influences sebaceous gland activity and sebum lipid composition. The degree to which this reduction translates to C. acnes depletion is plausible mechanistically but has not been quantified in a prospective longitudinal design. unsourced

Phylotype shift with age

Age-associated reduction in C. acnes dominance is accompanied by a phylotype distribution shift — youth skin is IA1-heavy (also consistent with the higher acne prevalence in young adults), while aging shifts the residual C. acnes population toward IB/II/III phylotypes that are more commensal-skewed ³. This phylotype shift may have dual effects:

Reduced acne risk in older adults (IB/II/III are less acne-promoting) — consistent with the well-known age-related decline in acne vulgaris.
Reduced pathogen exclusion capacity if the commensal C. acnes population drops below an effective threshold, allowing S. aureus colonization of dry or eczematous aged skin.

The mechanistic basis for the phylotype shift is not established; it may reflect changes in sebum lipid composition, immune senescence modifying selection pressure, or microenvironmental changes in the aging follicle. no-mechanism

Skin barrier implications

Age-related C. acnes decline may impair barrier function through two mechanisms:

Reduced FFA production → reduced skin surface acidity → elevated skin pH → impaired lipid-processing enzyme activity (serine proteases are pH-sensitive) → reduced barrier lipid synthesis. Skin pH rises ~0.5–1.0 units between young adulthood and late life; the microbial contribution to this shift is not quantified separately from sebocyte and cornified-envelope changes. no-mechanism
Loss of competitive exclusion → S. aureus colonization, which is associated with skin barrier disruption via V8 protease cleavage of desmoglein-1. The S. aureus – C. acnes ecological balance is particularly relevant to the interface between aging skin and atopic dermatitis, which increases in prevalence in older adults. needs-replication

Inflammatory / pathogenic associations

Acne vulgaris

C. acnes (predominantly phylotype IA1) drives inflammatory acne through multiple mechanisms ⁴ ⁹:

Biofilm formation in the follicular canal, protecting bacteria from antibiotics and immune clearance.
NLRP3 inflammasome activation and Th17 pathway induction: C. acnes lipases, pore-forming toxins (CAMP factors), and porphyrins activate keratinocytes and sebocytes to produce IL-1β, IL-8, IL-17A, and TNF-α.
TLR2/TLR4 signaling: C. acnes surface molecules (lipoteichoic acid, peptidoglycan) engage TLR2 on keratinocytes, driving NF-κB-dependent cytokine release. The Th17/IL-17 axis is now understood as a central amplifier of follicular inflammation downstream of C. acnes recognition.

Acne is not primarily an aging disease (prevalence peaks in adolescence), but acne scarring, post-inflammatory hyperpigmentation, and late-onset acne (40s–50s, often hormone-driven) represent aging-relevant sequelae. Chronic low-grade follicular inflammation from C. acnes also contributes to photoaging by amplifying UV-induced cytokine cascades. unsourced — the acne-photoaging amplification claim needs a primary source.

Prosthetic joint and device infections

C. acnes can shift from skin commensal to opportunistic pathogen in deep-seated infections — systemic bloodstream infections, bone/joint infections, and deep tissue infections — particularly in older, immunocompromised patients ¹⁰. Unlike its acne pathobiont role, in systemic contexts C. acnes colonizes sterile anatomical compartments, often from adjacent skin. Genomic analysis of 45 isolates (18 healthy control skin isolates vs 27 clinical infection isolates) shows that infection-associated isolates distribute across phylotypes IA1, IB, and II, with metabolic-pathway and DNA-repair gene differences rather than classic virulence-factor differences separating commensal from infection-associated strains — no significant differences in virulence gene content were found between groups ¹⁰. The distinction instead lies in single-nucleotide polymorphisms (SNPs) in housekeeping genes. Aging is a risk factor for deep-seated C. acnes infections through general immunosenescence. needs-replication — direct causal link between immunosenescence and C. acnes deep-tissue infection risk not established in longitudinal data.

Blepharitis and ocular surface disease

C. acnes colonizes eyelid margins and meibomian glands; phylotype IB-associated Cutibacterium modestum (formerly a C. acnes subspecies) was first isolated from inflamed meibomian glands in 2020. Posterior blepharitis (meibomian gland dysfunction) increases in prevalence with age and contributes to dry eye syndrome. The role of C. acnes vs Cutibacterium spp. in age-associated blepharitis is an emerging area. needs-replication

Therapeutic and intervention context

Acne treatment (conventional)

Standard acne treatments suppress C. acnes or its inflammatory downstream effects:

Topical antibiotics (clindamycin, erythromycin): suppress C. acnes growth; risk of dysbiosis and antibiotic resistance — the Dreno 2024 consensus review explicitly flags antibiotic-driven dysbiosis as a long-term concern ³.
Benzoyl peroxide (BPO): oxidant with bactericidal action on C. acnes; induces less resistance than antibiotics because it is non-selective. Often combined with antibiotics.
Topical and systemic retinoids (tretinoin, adapalene, isotretinoin): reduce sebum production, normalize follicular keratinization, downregulate TLR2. See retinoids.
Salicylic acid: keratolytic; reduces comedone formation; some antibacterial effect. See salicylic-acid.

Bakuchiol (aging-context antibacterial)

Bakuchiol, a plant-derived meroterpenoid marketed as a “natural retinol alternative” for photoaged skin, is a component of a BGM complex (bakuchiol + Ginkgo biloba extract + mannitol) that has demonstrated antibacterial activity against C. acnes (then P. acnes) in vitro and reduced porphyrin counts on skin clinically ¹¹ — distinct from bakuchiol’s retinoid-functional-analog mechanism on fibroblasts. The MIC of the BGM complex against P. acnes (strain CIP A 179) was 0.0005% for bakuchiol alone, comparable to zinc gluconate (0.12%) and erythromycin (0.0000125%). Clinical testing in 17 volunteers showed a significant decrease in porphyrin scores on the face at day 28 and day 56 (p<0.05). needs-replication — the in vitro antibacterial data for isolated bakuchiol and the clinical porphyrin reduction data are from a single industry-sponsored study; the clinical work tested BGM cream formulation (not isolated bakuchiol), and used the old P. acnes nomenclature. See bakuchiol for the full compound page.

In the aging context, bakuchiol’s contribution (within BGM complex) to antibacterial activity against C. acnes is most relevant to managing late-onset acne and preventing follicular inflammation in photoaged skin, rather than to the phylotype-shift/sebum-decline dynamics described above.

Skin microbiome-modulating interventions

Topical probiotics / postbiotics: applying commensal strains (including commensal C. acnes phylotypes or their metabolites) to skin is under investigation as an approach to restore microbiome balance without antibiotic disruption. The Shao 2025 probiotic C. acnes paper (antioxidant activity, Nrf-2 activation) represents early-stage characterization of a candidate topical probiotic strain ⁵.
Oral probiotics: the gut-skin axis hypothesis proposes that gut microbiome modulation (e.g., via Lactobacillus supplementation) reduces sebaceous gland inflammation via IGF-1 pathway modulation. Evidence is preliminary. See dysbiosis for the broader gut-skin axis.
Retinoids (topical): reduce sebum production via PPARG suppression → net reduction of C. acnes substrate; normalizes follicular environment. A downstream effect of retinoid use is altered skin microbiome composition, including reduced C. acnes abundance. This may be desirable in acne contexts but the implications for skin aging (barrier protection, pathogen exclusion) are not well-characterized. no-mechanism long-term-unknown

Extrapolation note

All claims on this page are from human studies (clinical, epidemiological, microbiome surveys) or human-cell in vitro experiments. C. acnes is a strict human/primate commensal; no relevant mouse or invertebrate model exists. Model-organism extrapolation tables are not applicable here.

Limitations and gaps

needs-replication — Phylotype-age distribution shift is a consistent observation across small cross-sectional studies, but no large (n>500) prospective longitudinal study tracking C. acnes phylotypes across the aging trajectory exists.
no-mechanism — Molecular mechanisms linking C. acnes abundance decline to skin barrier deterioration in aged skin are inferred but not directly measured.
needs-replication — Sebum decline magnitude and C. acnes decline correlation is mechanistically plausible and supported by cross-sectional microbiome data, but direct quantitative coupling in a single prospective cohort has not been published.
long-term-unknown — Whether restoration of C. acnes commensal phylotypes (via topical probiotics) improves skin barrier function or reduces inflammaging in older adults has not been tested in RCTs.
unsourced — Age-related changes in sebum lipid composition (saturated vs unsaturated FFA ratio) and their feedback on C. acnes growth dynamics: plausible from general sebaceous biology literature but not confirmed against a primary source on this page.
needs-replication — The contribution of C. acnes colonization decline specifically to skin surface pH rise with age is not quantified separately from corneocyte and sebocyte changes.
Wiki coverage gap — This page is the first skin-microbiome commensal entry in the wiki. Related stubs needed: [[skin-microbiome-aging-shifts]], [[staphylococcus-epidermidis]], [[malassezia]], [[sebaceous-gland]], [[epidermis]], [[skin-aging]] (exists), [[retinoids]], [[salicylic-acid]]. The bakuchiol page exists and should be updated to cross-link here.

Footnotes

doi:10.1099/ijsem.0.001367 · Scholz CFP, Kilian M · Int J Syst Evol Microbiol 2016;66(11):4422–4432 · taxonomic revision · Proposes Cutibacterium gen. nov. (and Acidipropionibacterium, Pseudopropionibacterium) for cutaneous propionibacteria; phylogenomic analysis confirms polyphyletic Propionibacterium; 455 citations per Crossref · not_oa; PDF not locally downloaded ↩ ↩²
doi:10.1016/j.chom.2024.06.002 · Yu T et al. · Cell Host & Microbe 2024 · multi-omics genomic study · “Multi-omics signatures reveal genomic and functional heterogeneity of Cutibacterium acnes in normal and diseased skin”; body site and skin disease shape C. acnes genomic diversity through HGT and selection; specific isolate count (1,234) not verified against full-text — paper is not_oa · not_oa; PDF not locally downloaded no-fulltext-access ↩ ↩² ↩³
doi:10.1111/jdv.19540 · Dreno B, Dekio I, Baldwin H, Demessant-Flavigny AL, Dagnelie MA, Khammari A, Corvec S · J Eur Acad Dermatol Venereol 2024 (accepted manuscript 2023) · review (66 refs) · six C. acnes phylotypes (IA1, IA2, IB, IC, II, III); IA1 predominance in acne; loss of phylotype diversity as central dysbiotic trigger; antibiotic-driven dysbiosis concern; dermocosmetic microbiome-supportive strategies · PDF at ↩ ↩² ↩³
doi:10.1007/s40257-020-00531-1 · Dreno B, Dagnelie MA, Khammari A, Corvec S · Am J Clin Dermatol 2020;21(Suppl 1):S18–S24 · review · skin microbiome dysbiosis and acne; phylotype IA1 virulence (CC18 / A1 SLST); S. epidermidis-C. acnes co-regulation; antibiotic-driven dysbiosis · PDF at ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶
doi:10.1111/jocd.70105 · Shao L et al. · J Cosmet Dermatol 2025;24:e70105 · in-vitro · commensal C. acnes CCSM0331 cell-free supernatant; DPPH/ABTS radical scavenging; Nrf-2 activation in keratinocytes; short-chain fatty acids and antioxidant enzymes · PDF locally available ↩ ↩² ↩³
doi:10.3389/fimmu.2018.02155 · Erdei L, Bolla BS, Bozó R, Tax G, Urbán E, Kemény L, Szabó K · Front Immunol 2018;9:2155 · in-vitro + ex vivo organotypic skin model · HPV-KER cells, NHEK cells; TNIP1 (TNFAIP3-interacting protein 1) as negative regulator of NF-κB downstream of TLR2/TLR4 C. acnes stimulation; TNIP1 expression dose-dependent, strain-independent; ATRA (all-trans retinoic acid) increases TNIP1, reduces TLR2-driven TNFα/CCL5 and attenuates TLR4-dependent inflammation · PDF at ↩
doi:10.3390/microorganisms12112179 · Jung Y et al. · Microorganisms 2024 · observational · n=60 Korean adults (n=30 aged 20–29 yr vs n=30 aged 60–75 yr; 50% male each group); whole-metagenome sequencing, nasolabial fold swabs · aging-induced decrease in C. acnes dominance (83.14 ± 22.18% in younger vs 60.55 ± 35.68% in older; p=0.007) and increased diversity (Shannon, Simpson, Chao1 all p<0.001) correlating with reduced skin elasticity and increased wrinkles · gold OA; PDF at ↩ ↩²
doi:10.3389/fragi.2025.1644012 · Swaney MH, Newman DJ, Mao J, Hilton AC, Worthington T, Li M · Front Aging 2025;6:1644012 · observational · n=59 UK adults (n=30 YA 26.7±4.45 yr; n=29 OA 72.3±4.04 yr); 16S rRNA V1-V3, face and antecubital fossa (arm) · C. acnes identified as key differentiating biomarker of skin microbiome across lifespan alongside S. hominis and diversity metrics; site-specific dynamics (face and arm differ); gender is a significant driving factor for facial changes · gold OA; PDF at ↩ ↩²
doi:10.1111/jdv.18794 · Mias C, Mengeaud V, Bessou-Touya S, Duplan H · J Eur Acad Dermatol Venereol 2023 · review · IA1 phylotype predominance activates Th17 pathway; loss of diversity as central driver of acne inflammation · not_oa; PDF not locally downloaded no-fulltext-access ↩
doi:10.3389/fcimb.2024.1433783 · Podbielski A, Köller T, Warnke P, Barrantes I, Kreikemeyer B · Front Cell Infect Microbiol 2024;14:1433783 · genomic (WGS, n=45 isolates: 18 healthy control skin + 27 clinical deep-seated infections) · commensal vs clinical isolate distinction via SNPs in housekeeping genes; infection isolates distribute across IA1, IB, II; no significant virulence-gene-content differences; metabolic-pathway and DNA-repair gene differences drive clinical vs commensal genomics · gold OA; PDF at ↩ ↩²
doi:10.2147/CCID.S110655 · Trompezinski S, Weber S, Cadars B, Larue F, Ardiet N, Chavagnac-Bonneville M, Sayag M, Jourdan E · Clin Cosmet Investig Dermatol 2016;9:233–239 · in-vitro + ex vivo + clinical · BGM complex (bakuchiol + Ginkgo biloba extract + mannitol); MIC of bakuchiol vs P. acnes CIP A 179 = 0.0005%; clinical n=17 volunteers (aged 19–34 yr, oily skin, mild-to-moderate acne); BGM cream reduced porphyrin scores at day 28 and day 56 (p<0.05); modulates sebum fatty acid composition (squalene, linoleic acid normalized) · Note: antibacterial effect is for BGM complex / bakuchiol as isolated compound; full formulation clinical data; industry-sponsored (NAOS/Bioderma) · PDF at ↩

🧬 Aging Wiki

Explorer

cutibacterium-acnes